Pharmafile Logo
Pharmafocus logo
Advanced Search
AstraZeneca imge

AZ begins late-stage trial of new cancer drug

October 22, 2013
Research and Development, Sales and Marketing AstraZeneca, Cancer, NSCLC, selumetinib

AstraZeneca has begun a Phase III study for its investigational lung cancer pill selumetinib in patients with a genetic sub-type …

News
gsk image

US regulator ponders Arzerra

October 22, 2013
Sales and Marketing Arzerra, CLL, FDA, GSK

GlaxoSmithKline and Genmab have submitted their blood cancer drug Arzerra to the FDA as a first-line treatment for chronic lymphocytic …

News
sian_dodwell_plbr

Former GSK director joins Publicis Life Brands Resolute

October 22, 2013
Manufacturing and Production, Research and Development, Sales and Marketing GSK, PLBR, publicis

Former director of branding and communications at GlaxoSmithKline Consumer Health Sian Dodwell, has joined Publicis Life Brands Resolute (PLBR) from …

Appointment
Actelion image

Opsumit wins US approval

October 22, 2013
Sales and Marketing actelion fda, opsumit

The FDA has approved Actelion’s oral endothelin receptor antagonist Opsumit as a treatment for pulmonary arterial hypertension (PAH), a potentially …

News

Effectively outsourcing medical and laboratory equipment procurement

October 21, 2013

With Investigator Sites located across the World it is increasingly important to ensure that they all have the right equipment …

Feature
Thought Leadership
iclusig image

Ariad ditches CML trial

October 21, 2013
Research and Development, Sales and Marketing Ariad, CML, iclusig

Ariad Pharmaceuticals has ditched its late-stage trial of Iclusig in patients with newly-diagnosed chronic myeloid leukemia (CML) after blood clots …

News
Eisai image

Eisai: reform NICE or we’ll pull out of the UK

October 21, 2013
Research and Development, Sales and Marketing Eisai, Hatfield, Hunt, NICE

Eisai has criticised NICE for being too narrow minded on assessing new drugs, and has warned it may pull its …

News

No closer to Alzheimer’s cure despite rise in research

October 21, 2013
Research and Development, Sales and Marketing Alzheimer's, depression, markram

A scientist charged with developing a digital model of the human brain has said that patients with neurological and neurodegenerative …

News
Herceptin image

The new paradigm in oncology drug marketing

October 21, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Herceptin, Roche, marketing, oncology

Twenty years ago drugs to treat cancer were made up of chemotherapy agents which are essentially ‘blunt tools’ against the …

Feature
jacek_glinka_mylan

Mylan hires president of European business

October 21, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mylan, glinka

Mylan has announced that from December Jacek Glinka will be the president of its European business. Glinka served as chief …

Appointment
fda image

Dust settles on US shutdown

October 21, 2013
Medical Communications, Sales and Marketing FDA, Obamacare, PhRMA, shutdown

The FDA has said that it was able to carry out a significant part of its remit during the suspension …

News
wockhardt image

MHRA recalls five Wockhardt medicines

October 18, 2013
Manufacturing and Production FDA, GMP, MHRA, Violations, Wockhardt, recall

The UK drugs regulator has recalled five more generic medicines made by Indian drugmaker Wockhardt after an inspection uncovered quality …

News
Adderall image

Shire slated following Adderall T-shirt controversy

October 18, 2013
Medical Communications, Sales and Marketing Adderall, EMA, FDA, Shire

A senior doctor and patient welfare advocate has criticised Shire after T-shirts emblazoned with the word ‘Adderall’ appeared for sale …

News
Roche image

Roche rules out merger talk

October 18, 2013
Sales and Marketing Cancer, Herceptin, Novartis, Roche, merger

Roche has dismissed talk of merging with fellow Swiss manufacturer Novartis as it revealed its results for the last three …

News
web_simon_bellamy_scm

SCM Pharma appoints new director

October 18, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing SCM Pharma, simon bellamy

Contract development and manufacturing organisation SCM Pharma has expanded its commercial management team with the appointment of a new director. …

Appointment

Astellas gets NICE nod

October 18, 2013
Sales and Marketing Cancer, NHS, NICE, Xtandi

Astellas Pharma’s new prostate cancer drug Xtandi which has been shown to shrink and kill cancer cells, has been recommended …

News
GSK China image

Travel ban ambiguity for GSK ‘s former China boss

October 17, 2013
Sales and Marketing China, GSK, bribery, reilly

GlaxoSmithKline has refuted reports that its former chief of Chinese operations is barred from leaving the country while he assists …

News
Quest diagnostics image

Quest starts selling BRCA tests

October 17, 2013
Sales and Marketing BRCA, Myriad, Quest, jolie

Quest Diagnostics has begun selling a genetic test to uncover the risk of hereditary breast cancer, after the US Supreme …

News

SHL to Inspire Innovation at the 2013 PDA Conference in Basel, Switzerland

October 17, 2013
Manufacturing and Production auto injector, auto-injector, autoinjector, autoinjector innovation, pen injector, shl pda basel

 

News
Press release

GCI Health expands with new London office

October 17, 2013
Medical Communications GCI Health, agency, comms

Healthcare communications agency GCI Health has officially opened its London office. The expansion, in response to the agency’s growing global …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026